The prenatal nutrition industry is moving toward targeted, science-backed solutions that benefit maternal and infant wellness. In this space, Aker BioMarine says docosahexaenoic acid (DHA) omega-3 is gaining renewed attention in the industry and among researchers for its role in fetal brain and eye development. The company highlights growing evidence around maternal DHA status, adding that bioavailability and sustainability are reshaping formulation strategies in supplements.
